Cardio Diagnostics Holdings Inc. WarrantCDIOW
About: Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.
Employees: 9
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
17% more funds holding
Funds holding: 6 [Q4 2024] → 7 (+1) [Q1 2025]
0% more ownership
Funds ownership: 1.85% [Q4 2024] → 1.85% (+0%) [Q1 2025]
59% less capital invested
Capital invested by funds: $96.7K [Q4 2024] → $39.6K (-$57.1K) [Q1 2025]
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Research analyst outlook
We haven’t received any recent analyst ratings for CDIOW.
Financial journalist opinion
We haven’t received any recent news articles for CDIOW.